March 2024: On March 14, 2024, the Court held an initial case management conference to discuss, among other things, various organizational and procedural issues, such as leadership structure for the plaintiffs, plaintiff fact sheets about the different GLP-1 receptor drugs that may have been taken and the alleged injuries that plaintiffs claim to have suffered as a result of taking the medications
Those who were in a smaller 4 milligram dose of retatrutide lost an average of 47 pounds, or about 19% of their body weight
Analysis of allelic variants in the catalase gene in patients with the skin depigmenting disorder vitiligo
Sharp, stabbing, or electric shock pain that shoots down the leg with movement, coughing, or sneezing
To provide a specific dosage of a particular ingredient
Ahmed and his team will monitor your progress and make adjustments as needed to support safe and consistent results.